San Francisco Bay Area biotech stories.
Friday, August 24, 2012
Peninsula biotech space feels global pharma blues
Compugen's Mary Haak-Frendscho.
The patent expirations and capital efficiency trends sweeping through the global drug industry are playing out in companies’ local real estate decisions
. That direction may not bode well in the short term for landlords and developers of biotech space on the Peninsula, with large biopharmaceutical companies buying tiny biotechs and consolidating multiple, smaller locations. But a new generation of biotech companies stands ready to take bits and pieces of the newly available space.
Share to Twitter
Share to Facebook
Share to Pinterest
Alexandria Real Estate Equities
BioMed Realty Trust
Post a Comment
Post Comments (Atom)